Importance of viral genomic composition in modulating glycoprotein content on the surface of influenza virus particles

Abstract Despite progress in our knowledge of the internal organisation of influenza virus particles, little is known about the determinants of their morphology and, more particularly, of the actual abundance of structural proteins at the virion level. To address these issues, we used cryo-EM to foc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Virology (New York, N.Y.) N.Y.), 2011-05, Vol.414 (1), p.51-62
Hauptverfasser: Moulès, Vincent, Terrier, Olivier, Yver, Matthieu, Riteau, Beatrice, Moriscot, Christine, Ferraris, Olivier, Julien, Thomas, Giudice, Emmanuel, Rolland, Jean-Paul, Erny, Alexandra, Bouscambert-Duchamp, Maude, Frobert, Emilie, Rosa-Calatrava, Manuel, Pu Lin, Yi, Hay, Alan, Thomas, Daniel, Schoehn, Guy, Lina, Bruno
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Despite progress in our knowledge of the internal organisation of influenza virus particles, little is known about the determinants of their morphology and, more particularly, of the actual abundance of structural proteins at the virion level. To address these issues, we used cryo-EM to focus on viral (and host) factors that might account for observed differences in virion morphology and characteristics such as size, shape and glycoprotein (GP) spike density. Twelve recombinant viruses were characterised in terms of their morphology, neuraminidase activity and virus growth. The genomic composition was shown to be important in determining the GP spike density. In particular, polymerase gene segments and especially PB1/PB2 were shown to have a prominent influence in addition to that for HA in determining GP spike density, a feature consistent with a functional link between these virus components important for virus fitness.
ISSN:0042-6822
1096-0341
DOI:10.1016/j.virol.2011.03.011